Previous Close | 0.1150 |
Open | 0.1150 |
Bid | 0.1100 x N/A |
Ask | 0.1150 x N/A |
Day's Range | 0.1100 - 0.1200 |
52 Week Range | 0.1050 - 0.2500 |
Volume | |
Avg. Volume | 168,528 |
Market Cap | 33.515M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2300 |
Earnings Date | Nov 30, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.42 |
Net Loss of $5.8 million, the fourth consecutive quarter of profitability improvementAdjusted EBITDA1 of $0.05 million, Adjusted EBITDA positive a quarter ahead of guidanceRevenue of $23.6 million, driven by 10% year over year organic growth on a normalized basis and $2.8 million in new ARR1 in the Health and Wellness divisionGross margin above 35% for the fourth consecutive quarterCash used in Operations of $3.5 million, Adjusted net cash used in operating activities1 $0.4 million, representing
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that the Company will release its financial results for the third quarter of 2023 on November 29, 2023, after market. CloudMD will hold its Q3 2023 earnings conference call and webinar on November 30, 2023, at 9:30 am ET (6:30 am PT). T
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, today announced that the Company now expects to release its financial results for the period ended September 30, 2023 (“Q3 2023”) on or before November 29, 2023. The Company’s auditor, KPMG LLP, has requested additional time to complete its review procedures.